Holders over time
- DGX
- CI
| Quarter | DGX | CI |
|---|---|---|
| Q3 2020 | 18 holders, $1.0bn | 34 holders, $18.1bn |
| Q4 2020 | 21 holders, $1.1bn | 22 holders, $21.9bn |
| Q1 2021 | 19 holders, $1.2bn | 24 holders, $23.9bn |
| Q2 2021 | 14 holders, $975m | 31 holders, $22.5bn |
| Q3 2021 | 17 holders, $1.1bn | 30 holders, $17.8bn |
| Q4 2021 | 17 holders, $1.5bn | 26 holders, $20.1bn |
| Q1 2022 | 16 holders, $812m | 28 holders, $20.4bn |
| Q2 2022 | 16 holders, $813m | 32 holders, $22.1bn |
| Q3 2022 | 16 holders, $910m | 31 holders, $21.5bn |
| Q4 2022 | 13 holders, $1.1bn | 30 holders, $24.7bn |
| Q1 2023 | 17 holders, $989m | 35 holders, $18.2bn |
| Q2 2023 | 16 holders, $1.3bn | 30 holders, $19.8bn |
| Q3 2023 | 15 holders, $1.1bn | 28 holders, $19.8bn |
| Q4 2023 | 11 holders, $1.2bn | 31 holders, $20.6bn |
| Q1 2024 | 10 holders, $777m | 28 holders, $24.0bn |
| Q2 2024 | 13 holders, $1.2bn | 28 holders, $19.5bn |
| Q3 2024 | 11 holders, $1.7bn | 25 holders, $20.2bn |
| Q4 2024 | 9 holders, $1.6bn | 23 holders, $15.2bn |
| Q1 2025 | 10 holders, $1.8bn | 24 holders, $18.4bn |
| Q2 2025 | 10 holders, $2.4bn | 34 holders, $19.5bn |
| Q3 2025 | 13 holders, $2.5bn | 28 holders, $16.2bn |
| Q4 2025 | 10 holders, $1.5bn | 21 holders, $14.6bn |
| Q1 2026 | 9 holders, $1.6bn | 26 holders, $13.5bn |
| Q2 2026 | 7 holders, $1.6bn | 28 holders, $13.0bn |
Quest Diagnostics Inc
- Holders
- 13
- Reported value
- $2.5bn
- Buyers
- 6
- Sellers
- 7
Breadth -1 among 95 comparable managers.
The Cigna Group
- Holders
- 28
- Reported value
- $16.2bn
- Buyers
- 14
- Sellers
- 15
Breadth -1 among 95 comparable managers.
Who holds both, Q3 2025
Both (5)
AllianceBernstein LP, Invesco Ltd, Neuberger Berman Group LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc
Only DGX (8)
Balyasny Asset Management LLC, Caxton Associates LLP, First Eagle Investment Management LLC, Marshall Wace LLP, Maverick Capital Ltd, Verition Fund Management LLC, Wellington Management Group LLP, Woodline Partners LP
Only CI (23)
Acadian Asset Management LLC, AQR Capital Management LLC, Arrowstreet Capital LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, D. E. Shaw & Co., Discovery Capital Management LLC, Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Freestone Grove Partners LP, GAMCO Investors Inc, Glenview Capital Management LLC, Greenlight Capital, Hudson Bay Capital Management LP, Man Group PLC, MFS Investment Management, Moore Capital Management LP, Quantbot Technologies LP, Renaissance Technologies LLC, Two Sigma Advisers LP, Two Sigma Investments LP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.